Targeting Uropathogenic Escherichia coli, a Virulent Stains of Urinary Tract Infection: In silico Study of Aloe Barbadensis Miller Phytoconstituents

S. Gurisha, Mikidadi and Rao, P.V.Kanaka and Cherupally, Laxmikanth (2024) Targeting Uropathogenic Escherichia coli, a Virulent Stains of Urinary Tract Infection: In silico Study of Aloe Barbadensis Miller Phytoconstituents. Journal of Pharmaceutical Research International, 36 (7). pp. 79-95. ISSN 2456-9119

[thumbnail of Gurisha3672024JPRI118217.pdf] Text
Gurisha3672024JPRI118217.pdf - Published Version

Download (1MB)

Abstract

The most frequent pathogen linked to the development of UTIs is Uropathogenic Escherichia coli (UPEC). Thus, inhibiting the UPEC protein target (PDB ID 8BVD) would be a viable treatment approach. This study used molecular docking and dynamics to investigate Aloe barbadensis miller antibacterial activity against UPEC bacteria. The Phytoconstituents of Aloe barbadensis miller such as aloe-emodin, cholic acid, and flavonol were downloaded from the PubChem database with nitrofurantoin as a control drug and investigated against the target molecule. Some potential parameters such as docking scores, absorption, distribution, metabolism, excretion, toxicity (ADMET), oral bioavailability, root mean square deviation (RMSD), root mean square fluctuation (RMSF), hydrogen bonding, radius of gyration, and total energy of the system were examined. According to the docking score results, all ligands showed excellent candidacy as an inhibitor of the 8BVD molecule. The score order was aloe-emodin (-6.6 kcal/mol), cholic acid (-6.8 kcal/mol), flavonol (-6.8 kcal/mol) and nitrofurantoin (-6.1 kcal/mol). Every ligand seemed to possess favorable drug-likeness characteristics and oral bioavailability. Molecular dynamics investigation showed that every ligand demonstrated a strong candidate for an inhibitor in its vicinity of 20 ns. Contrary to cholic acid, which appears to be more stable, aloe-emodin and flavonol showed comparatively high fluctuations. The results of this study imply that the chosen Phytoconstituents may be employed as 8BVD protein inhibitors to combat urinary tract infections. Nevertheless, the room is still available for more research to validate the particular mechanism of UTI treatment through clinical and experimental methods.

Item Type: Article
Subjects: STM Open Press > Medical Science
Depositing User: Unnamed user with email support@stmopenpress.com
Date Deposited: 07 Jun 2024 07:57
Last Modified: 07 Jun 2024 07:57
URI: http://journal.submissionpages.com/id/eprint/1877

Actions (login required)

View Item
View Item